This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Global Tissue Diagnostics Market, Forecast to 2022
Global Tissue Diagnostics Market, Forecast to 2022
Liquid Biopsy for Therapy Monitoring and Reimbursement Cuts Impede Long-term Prospects of Tissue Diagnostics Market
RELEASE DATE
10-May-2018
10-May-2018
REGION
North America
North America
Deliverable Type
Market Research
Market Research
Research Code: K25A-01-00-00-00
SKU: HC03009-NA-MR_21898
$4,950.00
In stock
SKU
HC03009-NA-MR_21898
Description
Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pathologists and is one of the most labor-intensive and time-consuming processes of clinical molecular diagnostic testing. It is estimated that 70% of the workflow in a histology laboratory is manual, and therefore, there is a need for automation.
The current challenges faced by the industry include shortage of qualified pathologists, consolidation of laboratories leading to shrinkage of the customer base, reimbursement cuts, and competition from novel technologies such as liquid biopsy and next generation sequencing. To address these challenges, vendors have resorted to technology innovation for automation, partnerships with pharmaceutical companies (for companion diagnostics), and information management system (to offer end-to-end solutions) to deepen solution expertise while catering to changing customer demands. Furthermore, the industry is also witnessing collaborations and M&As such as StatLab Medical Products with American MasterTech Scientific.
Research Scope
The key objectives of the market engineering for tissue diagnostics study are to highlight current market dynamics, key market participants, customer segments, and evolving business opportunities. The study aims to identify both established enterprises and startups, which are capable of shaping the future through best practices implementation, visionary leadership, and innovation in product offerings. Further, the study provides an analysis of market sizing by revenue segregated by pre-analytical staining, advanced staining, and anatomic pathology laboratory information systems. It covers the key drivers, challenges in the market impeding growth, competitive landscape, market participant strategies, reimbursement scenario, capital pricing, and future growth strategies. The study also highlights growth opportunities, key trends, mergers and acquisitions, notable partnerships, investment, and collaboration opportunities across regions such as the United States, Western Europe, Asia-Pacific, and Rest of the World (ROW).
Major participants mentioned in the study are Roche (Ventana), Leica Biosystems, Agilent (Dako), Sakura, Thermo Fisher Scientific, Biocare Medical, Abbott, Epic Systems, Cerner, NovoPath, and Sunquest, Xifin.
Key Issues Addressed
- What is the future outlook of tissue diagnostics market in the US, Western Europe, APAC, and Rest of the World?
- What are the growth opportunities in tissue diagnostics space which can be leveraged by existing and future participants?
- What constitutes a complete tissue diagnostics vendor landscape? How has the competitive landscape been characterized? Which vendors are dominating the market?
- How will the structure of the market change over time? Is it ripe for acquisitions?
- What are the key challenges that affect the uptake of automated systems in the US, Western Europe, APAC, and ROW?
RESEARCH: INFOGRAPHIC
This infographic presents a brief overview of the research, and highlights the key topics discussed in it.Click image to view it in full size
Table of Contents
Key Findings
Key Findings (continued)
Market Engineering Measurements
Scope and Segmentation
Key Questions this Study will Answer
Strategic Imperatives for the Tissue Diagnostics Market
6 Big Growth Themes for Tissue Diagnostics Market
Future Trends—Three Big Predictions Driving Tissue Diagnostics Market
Market Background
Market Segmentation
Trends in Tissue Diagnostics Market
Trends in Tissue Diagnostics Market (continued)
Trends in Tissue Diagnostics Market (continued)
Future of Pathology Laboratory
Regional Trends in Pathology Market
Regional Trends in Pathology Market (continued)
Market Drivers
Market Restraints
Market Engineering Measurements
Global Revenue Forecast
Global Revenue Forecast Discussion
Global Revenue Forecast by Segment
Global Revenue Forecast by Segment Discussion
Future Demand and Market Dynamics for APLIS
Percent Revenue Forecast by Region
Revenue Forecast by Region
Global Market Share Analysis
Top Competitors
Tissue Diagnostics Market Participant Strategies
Tissue Diagnostics Market Participant Strategies (continued)
Tissue Diagnostics Market Participant Strategies (continued)
Global Competitor Matrix
Global Competitor Matrix (continued)
Global Competitor Matrix (continued)
Global Competitor Matrix (continued)
Global Competitor Matrix (continued)
Global Competitor Matrix (continued)
Tissue Diagnostics Leaderboard
Notable Activities
Notable Activities (continued)
Notable Activities (continued)
Notable Activities (continued)
Notable Activities (continued)
Notable Activities (continued)
Growth Opportunity 1—Companion Diagnostics (CDx) to Drive Advanced Staining Techniques
Growth Opportunity 2—Workflow Shift Towards Integrated Histopathology Systems
Growth Opportunity 3—Converging Molecular and Pathology Workflow for Enhanced Efficiency
Growth Opportunity 4—Increasing Need for Automation & Digitization in Tissue Diagnostics
US Regional Snapshot
US Key Findings
US Revenue Forecast
US Revenue Forecast by Segment
US Revenue Forecast Discussion
US Country Analysis
US Market Share Analysis
US Market Share Analysis (continued)
US Changes to Pathology Reimbursement
CDx using Tissue Diagnostics Techniques
Comparison between Rate of Marketing of Tissue Diagnostic Techniques with PCR & NGS for CDx Combination Products
Comparison between Rate of Marketing of Tissue Diagnostic Techniques with PCR & NGS for Combination Products
Tissue and Companion Diagnostics Partnerships
US Capital Pricing Analysis
US Sales Channel Analysis
US Service Provider Analysis
US APLIS Competitor Landscape
US APLIS Competitor Landscape (continued)
US APLIS Competitor Landscape (continued)
US APLIS Competitor Landscape (continued)
US APLIS Competitor Landscape (continued)
US APLIS Competitor Landscape (continued)
US APLIS Competitor Landscape (continued)
US APLIS Competitor Landscape (continued)
US APLIS Competitor Landscape (continued)
US APLIS Competitor Landscape (continued)
Key Companies to Watch
Key Companies to Watch (continued)
Western Europe Regional Snapshot
Western Europe Market Analysis
Western Europe Tissue Diagnostics Market Outlook
Western Europe Revenue Forecast
Western Europe Revenue Forecast Discussion
Western Europe Revenue Forecast Discussion (continued)
Western Europe Revenue Forecast Discussion (continued)
Western Europe Revenue Forecast Discussion (continued)
Western Europe Revenue Forecast Discussion (continued)
Western Europe Percent Revenue Forecast by Region
Western Europe Revenue Forecast by Region
Western Europe Revenue Forecast by Segment
Western Europe Revenue Forecast by Segment Discussion
UK Country Analysis
UK Revenue Forecast Discussion
Germany Country Analysis
Germany Revenue Forecast Discussion
France Country Analysis
France Revenue Forecast Discussion
Scandinavia Country Analysis
Scandinavia Revenue Forecast Discussion
Benelux Country Analysis
Benelux Revenue Forecast Discussion
Italy Country Analysis
Spain Country Analysis
Western Europe Market Share Analysis
Western Europe Market Share Analysis (continued)
Key Companies to Watch
Key Companies to Watch (continued)
APAC Regional Snapshot
APAC Market Analysis
APAC Tissue Diagnostics Market Outlook
APAC Revenue Forecast
APAC Revenue Forecast Discussion
APAC Percent Revenue Forecast by Region
APAC Revenue Forecast by Region
APAC Revenue Forecast by Segment
APAC Revenue Forecast by Segment Discussion
China Country Analysis
China Revenue Forecast Discussion
India Country Analysis
India Revenue Forecast Discussion
Japan Country Analysis
Japan Revenue Forecast Discussion
ASEAN Overall Forecast
ASEAN Revenue Forecast Discussion
Indonesia Country Analysis
Thailand Country Analysis
Singapore Country Analysis
Malaysia Country Analysis
APAC Market Share Analysis
APAC Market Share Analysis (continued)
Key Companies to Watch
ROW—Regional Snapshot
ROW Revenue Forecast
ROW Revenue Forecast by Segment
Revenue Forecast Discussion
Revenue Forecast Discussion (continued)
Revenue Forecast Discussion (continued)
Future Trends—Three Big Predictions Driving Tissue Diagnostics Market
Legal Disclaimer
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
List of Exhibits (continued)
Market Engineering Methodology
US CPT Code based Pathology Reimbursement
US CPT Code based Pathology Reimbursement (continued)
Marketed CDx Combination Products in the US—Immunohistochemistry (IHC)
Marketed CDx Combination Products in the US—In situ Hybridization (ISH)
Marketed CDx Combination Products in the US—Next Generation Sequencing (NGS)
Marketed CDx Combination Products in the US—Polymerase Chain Reaction (PCR)
US Capital Pricing Data Table
US Capital Pricing Data Table (continued)
US Capital Pricing Data Table (continued)
US Capital Pricing Data Table (continued)
US Capital Pricing Data Table (continued)
US Capital Pricing Data Table (continued)
Popular Topics
Tissue diagnostic techniques are used to recognize specific antigens in preserved tissues. The process includes slicing thin tissue samples that are treated with a hematoxylin and eosin (H&E) stain, and then are formalin-fixed paraffin-embedded (FFPE) to diagnose tumors and other histopathology specimens. This has traditionally required skilled pathologists and is one of the most labor-intensive and time-consuming processes of clinical molecular diagnostic testing. It is estimated that 70% of the workflow in a histology laboratory is manual, and therefore, there is a need for automation.
The current challenges faced by the industry include shortage of qualified pathologists, consolidation of laboratories leading to shrinkage of the customer base, reimbursement cuts, and competition from novel technologies such as liquid biopsy and next generation sequencing. To address these challenges, vendors have resorted to technology innovation for automation, partnerships with pharmaceutical companies (for companion diagnostics), and information management system (to offer end-to-end solutions) to deepen solution expertise while catering to changing customer demands. Furthermore, the industry is also witnessing collaborations and M&As such as StatLab Medical Products with American MasterTech Scientific.--BEGIN PROMO--
Research Scope
The key objectives of the market engineering for tissue diagnostics study are to highlight current market dynamics, key market participants, customer segments, and evolving business opportunities. The study aims to identify both established enterprises and startups, which are capable of shaping the future through best practices implementation, visionary leadership, and innovation in product offerings. Further, the study provides an analysis of market sizing by revenue segregated by pre-analytical staining, advanced staining, and anatomic pathology laboratory information systems. It covers the key drivers, challenges in
| Deliverable Types | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Supratik Paul |
| Industries | Healthcare |
| WIP Number | K25A-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9562-B1,9568-B1,9571-B1,9573-B1,9600-B1,9611-B1,9627-B1,9825-B1,99BF-B1,99C0-B1,99C1-B1,99C6-B1,99C9-B1,99CB-B1,9A06-B1,9A40-B1,9A41-B1,9A42-B1,9A43-B1,9A44-B1,9A4E-B1,9A4F-B1 |